Shots:Pharmanovia has signed an exclusive in-licensing agreement with Radius Health for abaloparatide (US brand name: Tymlos) to treat osteoporosis, expanding its osteoporosis franchise
Pharmanovia will handle clinical, regulatory & commercial responsibilities across APAC region (China, Singapore, Thailand, Indonesia, Vietnam, Taiwan, Hong Kong, Malaysia, Macau & Philippines), while Radius will get an upfront, regulatory…
To keep our readers acquainted with several disease conditions, ongoing trials, and available treatment options, PharmaShots brings every month a detailed take on a particular disease after thorough research Continuing the series for the disease of the month, PharmaShots brings a condensed report on Osteoporosis, a bone and tissue disorder October 20th is observed as…
Shots:Laura spoke about the non-drug intervention study to treat osteopenia in postmenopausal womenShe also talked about the company’s OsteoBoost technology which is a convenient treatment to improve bone densityThe interview provides an understanding of the company’s vision to develop new treatment options for osteoporosis and osteopeniaSmriti: Brief us about the background behind…
